EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications

Maureen George, Bradley E Chipps, David A Beuther, William McCann, Joan Reibman, Robert A Wise, Robert S Zeiger, Ileen Gilbert, James M Eudicone, Hitesh N Gandhi, Karin S Coyne, Gale Harding und 3 weitere

Therapeutic Advances in Respiratory Disease · 2025-10 · 19

DOI: 10.1177/17534666251384465 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 18.10.2025. Verfasst von Maureen George und 14 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University School of Nursing, New York, NY, USA. Hauptthemen laut MEDLINE: Asthma, Quality of Life, Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

What is this summary about? • The Asthma Impairment and Risk Questionnaire (AIRQ ® ) has been designed and tested to measure patients’ levels of asthma control in a healthcare setting. • Unlike other available questionnaires that only assess asthma symptoms that can be bothersome or limit a person’s activities and quality of life (impairment-related symptoms), the AIRQ also includes questions related to risk of an asthma attack. This allows for a broader measurement of asthma control and a prediction of the chance of having future asthma attacks. • AIRQ scores are linked to a patient’s own experience of their health and how it impacts their daily life (health-related quality of life). • The AIRQ may make it easier for patients and healthcare professionals to have shared decision-making discussions that can lead to better asthma care and asthma outcomes. • This document summarizes several published studies of the AIRQ in people with asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaQuality of LifeLungHumansSurveys and QuestionnairesRisk AssessmentRisk FactorsDecision Making, SharedPlain Language Summaries

Stichwörter der Autor:innen

AIRQasthmaasthma attacksasthma symptomsquestionnaire

Autor:innen und Institutionen

  • Columbia University School of Nursing, New York, NY, USA.
  • Capital Allergy & Respiratory Disease Center, Sacramento, CA, USA.
  • National Jewish Health, Denver, CO, USA.
  • Allergy Partners of Asheville, Asheville, NC, USA.
  • New York University Grossman School of Medicine, New York, NY, USA.
  • The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Förderung

  • AstraZeneca

Zitieren

APA

George, M., Chipps, B. E., Beuther, D. A., McCann, W., Reibman, J., Wise, R. A., Zeiger, R. S., Gilbert, I., Eudicone, J. M., Gandhi, H. N., Coyne, K. S., Harding, G., Cutts, K., Ross, M., & Murphy, K. R. (2025). What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications. Therapeutic Advances in Respiratory Disease, 19. https://doi.org/10.1177/17534666251384465

Vancouver

George M, Chipps BE, Beuther DA, McCann W, Reibman J, Wise RA, et al. What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications. Therapeutic Advances in Respiratory Disease. 2025;19. doi:10.1177/17534666251384465

BibTeX
@article{George2025,
  author = {George, Maureen and Chipps, Bradley E and Beuther, David A and McCann, William and Reibman, Joan and Wise, Robert A and Zeiger, Robert S and Gilbert, Ileen and Eudicone, James M and Gandhi, Hitesh N and Coyne, Karin S and Harding, Gale and Cutts, Katelyn and Ross, Melissa and Murphy, Kevin R},
  title = {What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2025},
  volume = {19},
  doi = {10.1177/17534666251384465}
}
Kostenlos starten →